Page of

Index 

Index
Source:
Treating and Preventing Adolescent Mental Health Disorders: What We Know and What We Don't Know. A Research Agenda for Improving the Mental Health of Our Youth
Abuse
alcohol. See[link]
child
depression and, [link], [link]
neuroendocrine changes, [link]
suicidal behavior and, [link]
drug. See[link]
physical, suicidal behavior and, [link]
sexual. See[link]
Access
to mental health services
cultural barriers, [link]
in schools, [link], [link], [link]t, [link]t
survey findings, [link], [link], [link]
system barriers, [link]
to substance abuse treatment
barriers, [link]
for step-down services, [link]
system change considerations, [link]
Acute stress disorder, [link]
Addiction. See[link]
ADHD. See[link]
Adolescence. See also[link]
age range, [link]
biological features, [link]
brain development during, [link] [link], [link]f, [link]
definition, [link] [link]
environmental context, [link]
hormonal changes, [link] , [link]
mental health problems during. See[link]; specific disorders
substance use during. See[link]; [link]
weight loss interventions during, [link]
Adolescent Suicide Awareness Program, [link], [link]t
Adolescent Transitions Program, [link]
Adrenal hormones, and adolescent behavior, [link] [link]
Adventure programs, [link], [link]t
Affective disorders. See[link]
African Americans
access to mental health services, [link]
depression, [link], [link]
substance use, [link]
suicide rate, [link]
After-school programs, for positive youth development, [link], [link]
Aggressive behavior. See also[link]
and suicide, [link]
Agoraphobia, [link], [link]
Alaskan Natives, suicide rate, [link]
Alcohol dehydrogenase, [link]
Alcohol use and abuse
and alcohol dependence as adult, [link]
anxiety and, [link]
clinical aspects, [link], [link]t
cocaine and, [link]
in college setting, [link]
consequences, [link]
detoxification, [link]
in “gateway” hypothesis, [link]
general description, [link]
genetics, [link]
prevalence, [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
problematic, [link], [link]t
school professional findings, [link], [link]t
and use of emergency department, [link]
withdrawal, [link], [link]t
zero-tolerance policies, [link]
Alcohol use disorders (AUDs)
comorbidity, [link]
etiology, [link]
issues in determining, [link]
pharmacotherapy, [link]
prevalence, [link]
Allostasis, brain reward center, in substance use disorders, [link]
Alprazolam, for panic disorder, [link]
Amenorrhea, in anorexia nervosa, [link], [link]
American Academy of Pediatrics, eating disorders treatment guidelines, [link]
American Foundation for Suicide Prevention, [link], [link]t, [link]
American Indians, suicide rate, [link]
American Psychiatric Association, eating disorders treatment guidelines, [link]
American Psychological Association, standards for evidence-based mental health services, [link]
Amphetamine abuse. See also[link]
in adolescence, [link]
schizophrenia and, [link]
Amygdala
activating factors, [link]
in anxiety disorders, [link]
developmental changes, [link] [link]
extended, in drug addiction, [link]
Anandamide, [link]
Angel dust, [link]
Animal models, substance use disorders, [link], [link]f, [link]f
Annenberg Public Policy Center
primary care physician survey, [link]
school mental health professionals survey, [link]
Annie E. Casey Foundation Blue Sky Project, [link]
Anorexia nervosa. See also[link]
age differences, [link]
binge eating/purging subtype, [link], [link]t
combination therapy, [link]
comorbidity, [link], [link], [link]
diagnostic criteria, [link], [link]t, [link], [link]
diagnostic migration, [link], [link]
dieting and, [link], [link]
DSM-IV criteria, [link], [link]t, [link]
epidemiology, [link], [link]t, [link]t, [link]
etiology, [link]
full-syndrome, [link], [link]
genetics, [link]
inpatient treatment, [link]
medical complications, [link], [link]t, [link]
osteopenia in, [link], [link]
outcome, [link], [link]
outpatient treatment, [link]
partial-syndrome, [link]
pharmacotherapy, [link], [link]
prevalence, [link], [link], [link]t, [link]t
prevention programs, [link]
combined, [link]
in high-risk populations and settings, [link]
research agenda, [link]
targeted, [link]
universal, [link]
psychosocial therapy, [link]
evaluation, [link]
randomized controlled trials, [link]
relapse prevention, [link]
refeeding in, [link]
relapse prevention, [link], [link], [link]
restricting subtype, [link], [link]t
risk factors, [link], [link]t, [link]
biological, [link]
eating and weight-related, [link]
environmental, [link]
general, [link]
genetic, [link]
individual, [link]
weight restoration, [link]
Antepartum depression, [link]
Anticonvulsants, in schizophrenia, [link]
Antidepressants. See also specific drugs
for anorexia nervosa, [link], [link]
for bipolar disorder, [link]
for bulimia nervosa, [link], [link]
for generalized anxiety disorder, [link], [link]
heterocyclic, for major depressive disorder, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link]
combination and augmentation therapy, [link], [link], [link]
public health advisory on, [link]
in schizophrenia, [link]
selective serotonin and noradrenaline reuptake inhibitor, for major depressive disorder, [link]
selective serotonin reuptake inhibitor. See[link]
suicidal ideation and, [link] [link], [link], [link], [link]
for suicide attempters, [link], [link]
tricyclic
for generalized anxiety disorder, [link], [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t
for panic disorder, [link]
Antipsychotics. See also specific drugs
atypical
for anorexia nervosa, [link]
for bipolar disorder
in adults, [link]
with mood stabilizers, [link]
for major depressive disorder, [link]
for schizophrenia
acute treatment, [link], [link]t, [link]
adjuncts to, [link]
maintenance treatment, [link], [link]t
side effects, [link]
Anxiety disorders, [link]
age differences, [link]
autonomic nervous system abnormalities, [link], [link]
biological correlates, [link]
biological features, [link]
brain developmental changes, [link]
brain imaging, [link]
cognitive-behavioral therapy, [link]
developmental considerations, [link]
education and skill-building, [link]
exposure exercises, [link]
history and rationale, [link]
maintenance of gains, [link]
mechanisms, [link]
with pharmacotherapy, [link]
recommendations, [link]t
research agenda, [link]
cognitive factors, [link], [link], [link]
community factors, [link]
comorbidity, [link], [link]t
alcohol use disorders, [link]
bipolar disorder, [link]
depression, [link], [link], [link], [link]
eating disorders, [link], [link], [link]
substance use disorder, [link]
criminal behavior and, [link]
defining, [link], [link]
descriptions, [link], [link]
disability requirement, [link]
electroencephalography, [link]
emotional processing theory, [link]
environmental factors, [link]
etiology and maintenance theories, [link]
exposure therapy, mechanisms, [link], [link]
family factors, [link]
fear structures
cognitive-behavioral therapy and, [link]
emotional processing theory and, [link]
gang affiliation and, [link]
gender differences, [link]
generalized
in children and adolescents, [link]
comorbidity, [link], [link]t
description, [link]
genetics, [link], [link]t
signs and symptoms, [link]t
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
genetics, [link], [link]t, [link]
HPA axis in, [link]
immunology, [link]
learning theories, [link]
neurobiology, [link], [link]
neurochemistry, [link]
neuroticism and, [link]
obsessive-compulsive disorder as. See[link]
onset and course, [link]
panic disorder as. See[link]
peer factors, [link]
pharmacotherapy
with cognitive-behavioral therapy, [link]
rationale, [link]
recommendations, [link]t
research agenda, [link]
post-traumatic stress disorder as. See[link]
prevalence, [link]
prevention, [link]
early detection and screening, [link]
issues, [link]
model programs, [link]
outcome evaluation, [link]
research agenda, [link]
risk factors and protective factors, [link], [link]t
theoretical models, [link]
prevention programs, [link]
indicated, [link]
selective, [link]
universal, [link]
primary care physician findings, [link], [link]t, [link], [link], [link], [link]t
rating scales, [link]
relapse prevention, [link]
research agenda, [link]
risk factors, [link], [link]t
school factors, [link]
school professional findings, [link], [link]t
signs and symptoms, [link]t
smoking and, [link]
social. See[link]
social support and, [link]
substance abuse and, [link], [link]
subsyndromal anxiety symptoms versus, [link], [link]
suicidal behavior and, [link]
threat bias in
attentional, [link]
interpretative, [link]
treatment, [link]
acute, [link], [link]t
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
outcome summary, [link]t
research agenda, [link]
Anxiety Disorders Interview Schedule for Children, [link]
Anxiety sensitivity, [link]
Applied Suicide Intervention Skills Training (ASIST), [link], [link]t, [link]
Arnarson and Craighead program for prevention of depression, [link]
Asian Americans, suicide rate, [link]
Association studies, in schizophrenia, [link]
Asthma, depression and, [link]
Attachment
as outcome of positive youth development, [link]
security in, depression and, [link]
styles
anorexia nervosa and, [link]
anxiety disorders and, [link]
Attachment-based family therapy, for major depressive disorder, [link]
Attention deficit, in children of schizophrenic parents, [link], [link]
Attention-deficit/hyperactivity disorder, comorbidity
alcohol use disorder, [link]
bipolar disorder, [link]
depression, [link], [link]
substance use disorder, [link]
Attentional threat bias, in anxiety disorders, [link]
Attributional style, pessimistic
suicidal behavior and, [link]
and vulnerability to depression, [link]
Attributions, stigma and, [link]
Australia, depression prevention programs, [link]
Automobile accidents, alcohol-related, [link]
Autonomic nervous system abnormalities, in anxiety disorders, [link], [link]
Ballet dancers, anorexia nervosa in, [link], [link]
Basal ganglia, and motor dysfunction in schizophrenia, [link]
Beardslee program for prevention of depression, [link]
A Beautiful Mind, [link]
Behavior genetic theory of substance abuse, [link]
Behavioral competence, as outcome of positive youth development, [link]
Behavioral inhibition
and anxiety disorders, [link]
and depression, [link]
selective prevention intervention for, [link]
Behavioral managed care, [link]
Behavioral problems, premorbid, in schizophrenia, [link], [link], [link]t, [link], [link], [link]
Behavioral therapy. See also[link]
dialectical, for suicidal behavior, [link]t, [link]
for major depressive disorder, [link]
for selective mutism, [link]t, [link]
for separation anxiety disorder, [link]
for substance use disorders, [link]
for suicidal behavior, [link]
Belief in future, as outcome of positive youth development, [link]
Benzodiazepines
for generalized anxiety disorder, [link], [link]
for panic disorder, [link], [link]
for phobia, [link]
in schizophrenia, [link]
for separation anxiety disorder, [link]
Bibliotherapy, for subsyndromal depression, [link]
Big Brothers and Big Sisters, [link]t
Binge drinking, [link]f, [link]
Binge eating
in adolescents, [link]
in anorexia nervosa, [link], [link]t
in bulimia nervosa, [link]
Binge eating disorder, [link], [link]
Biological factors. See also[link]
in anorexia nervosa, [link]
in anxiety disorders, [link]
in positive youth development, [link]
in suicidal behavior, [link]
Bipolar disorder
age of onset, [link], [link]
brain abnormalities, [link]
classic (type I), [link]
community attitudes toward, [link], [link]t
comorbidity, [link], [link]
diagnosis, [link]
epidemiology, [link], [link]
family history and, [link]
genetics, [link], [link]t
hypomania in (type II), [link]
hypothalamic-pituitary-adrenal axis hyperactivity, [link]
mania in
diagnostic criteria, [link]
mixed, [link]
not otherwise specified, [link]
pharmacotherapy
in adolescents, [link], [link]t
in adults, [link]
combination therapy, [link]
maintenance therapy, [link]
prepubertal, versus adolescent-onset, [link]
prevention research agenda, [link], [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
psychosocial therapy, [link]
rates, [link], [link]t, [link]t
research agenda, [link]
risk factors, [link]
substance abuse and, [link], [link]
suicidal behavior and, [link]
treatment research agenda, [link]
Birth cohort studies, in schizophrenia, [link], [link], [link]t
Blood alcohol level (BAL), [link]
Blood phobia, [link]
Blue Sky Project, [link]
Body dissatisfaction
anorexia nervosa and, [link]
bulimia nervosa and, [link]
Body fat, fear of, as criterion for anorexia nervosa, [link]
Body mass index
anorexia nervosa and, [link]
bulimia nervosa and, [link]
Bonding, as outcome of positive youth development, [link]
Bone mineral density, in anorexia nervosa, [link]
Borderline personality disorder, plus suicidal behavior, dialectical behavioral therapy for, [link]
Brain. See also[link]
abnormalities
in anxiety disorders, [link]
in children of schizophrenic parents, [link]
in mood disorders, [link]
violence exposure and, [link]
circuitry
developmental shifts, [link] [link]
in schizophrenia, [link]
development
during adolescence, [link] [link], [link]f, [link]
myelinization, [link] [link], [link]f
synaptic pruning, [link] [link], [link]f, [link]
executive inhibitory circuitry defects, in substance use disorders, [link]
imaging
in anxiety disorders, [link]
in mood disorders, [link]
in schizophrenia, [link]
in substance use disorders, [link]
reward center dysregulation, [link], [link]
allostasis and, [link]
animal models, [link], [link]f, [link]f
imaging studies, [link]
pharmacotherapy for, [link]
volume
developmental changes, [link] [link], [link]f, [link]
in schizophrenia, [link]
Brief dynamic therapy, for major depressive disorder, [link]
Brief interventions, for substance use, [link]
Brief strategic family therapy, for substance use disorders, [link]
Bulimia nervosa. See also[link]
combination therapy, [link]
comorbidity, [link], [link]
diagnostic criteria, [link], [link]t, [link]
dieting and, [link], [link]
DSM-IV criteria, [link], [link]t
epidemiology, [link], [link]t, [link]t, [link]
etiology, [link]
full-syndrome, [link]
genetics, [link]
medical complications, [link]t, [link], [link]
outcome, [link], [link]
partial-syndrome, [link]
pharmacotherapy, [link], [link]
prevalence, [link], [link], [link], [link]t, [link]t
prevention programs, [link]
combined, [link]
in high-risk populations and settings, [link]
research agenda, [link]
targeted, [link]
universal, [link]
psychosocial therapy, [link], [link]
relapse prevention, [link], [link], [link]
risk factors, [link], [link]
Bullying
school professional findings, [link], [link]t
suicidal behavior and, [link]
Buprenorphine, for opioid addiction, [link], [link]
Bupropion
for ADHD plus substance use disorder, [link]
for major depressive disorder, [link]
for smoking cessation, [link]
Buspirone, for generalized anxiety disorder, [link], [link]
Calcium supplementation, in anorexia nervosa, [link]
California, reform initiatives on delivery of evidence-based practices, [link]
Caloric requirements, [link]
Cannabis. See[link]
Carbamazepine
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
for post-traumatic stress disorder, [link]
Cardiovascular system
in anxiety disorders, [link], [link]
in eating disorders, [link]t
Caring School Community, [link]t
CASASTART (Striving Together to Achieve Rewarding Tomorrows), [link]
Case identification, in mental health disorders, [link], [link]
CASEL (2003), [link]t
Catatonic features, depression with, [link]
Catchment approach, for prevention of substance abuse, [link]
Catechol-O-methyl transferase (COMT), as schizophrenia susceptibility gene, [link], [link]
CBT. See[link]
Center for Mental Health Services System of Care, [link]
Center for Prevention Research, [link]
Central intake unit, for substance abuse treatment, [link]
Cerebellum, developmental changes, [link] [link]
Change
consensual theory of, in positive youth development field, [link]
organizational readiness, [link]
Character strengths, [link], [link]
Chemical dependency. See[link]
Chemical transmission
in anxiety disorders, [link]
in drug addiction, [link]
Child abuse
depression and, [link], [link]
neuroendocrine changes, [link]
suicidal behavior and, [link]
Child and Adolescent Service System Program (CASSP), [link]
Child and Adolescent Trauma Screen (CATS), [link]
Child Behavior Checklist (CBCL), [link]
Child PTSD Symptom Scale (CPSS), [link]
Child Trends, [link], [link]t
Child welfare system, substance abuse identification, [link]
Childhood Anxiety Sensitivity Index (CASI), [link], [link]
Children. See also[link]
abuse of. See[link]
bipolar disorder in, versus adolescent-onset, [link]
generalized anxiety disorder in, [link]
major depressive disorder in
versus adolescent-onset, [link], [link]
antidepressants for, [link]
psychosocial therapy, [link]
obsessive-compulsive disorder in, [link]
panic disorder in, [link]
phobia in, [link]
post-traumatic stress disorder in, [link]
at risk for schizophrenia, longitudinal studies, [link], [link], [link], [link]t, [link]
schizophrenia in, event-related potentials in, [link], [link]t
social anxiety disorder in, [link]
weight loss interventions for, [link]
CHRNA7, as schizophrenia susceptibility gene, [link]
Cigarette smoking. See[link]
Citalopram, for major depressive disorder, [link], [link], [link]t
Clarke program for prevention of depression, [link]
Classical conditioning
in anxiety disorders, [link]
in substance use disorders, [link]
Climate, organizational, [link]
Clinic-community intervention model for treatment development, [link]
Clomipramine
for obsessive-compulsive disorder, [link], [link]
for panic disorder, [link]
Clonazepam, for panic disorder, [link], [link]
Clonidine, for post-traumatic stress disorder, [link]
Clozapine
for bipolar disorder, [link]
for psychotic disorder and suicidal behavior, [link]
for schizophrenia, [link]t, [link]t, [link]t, [link]
for suicide attempters, [link]
Club drugs, [link]
Cocaine use, [link], [link]t
alcohol and, [link]
clinical aspects, [link], [link]t
genetics, [link]
medical complications, [link]
treatment, [link]
withdrawal, [link], [link]t
Cognitive-behavioral analysis system of psychotherapy, for major depressive disorder, [link]
Cognitive-behavioral therapy
for anorexia nervosa, [link]
for anxiety disorders
developmental considerations, [link]
education and skill-building, [link]
exposure exercises, [link]
history and rationale, [link]
maintenance of gains, [link]
mechanisms, [link]
with pharmacotherapy, [link]
recommendations, [link]t
research agenda, [link]
for bipolar disorder, [link]
for bulimia nervosa, [link], [link], [link]
for eating disorders, [link], [link]
for generalized anxiety disorder, [link]t, [link], [link]
for major depressive disorder
in adults, [link], [link]
in children and adolescents, [link], [link]t, [link]f, [link]t
in Latino youth, [link]
with pharmacotherapy, [link]
prevention programs, [link], [link]
symptomatic community samples, [link]
for obsessive-compulsive disorder, [link]t, [link], [link]
for panic disorder, [link]t, [link], [link], [link]
for phobia, [link]t, [link]
for post-traumatic stress disorder, [link]t, [link], [link], [link], [link]
for schizophrenia, [link], [link]
for separation anxiety disorder, [link]t, [link]
for social anxiety disorder, [link]t, [link]
for substance use disorders, [link]
for subsyndromal depression, [link]
for suicidal adults, [link]
for suicidal youth, [link], [link], [link]t, [link]
Cognitive competence, as outcome of positive youth development, [link]
Cognitive diathesis-stress model, of depression, [link]
Cognitive factors, in anxiety disorders, [link], [link], [link]
Cognitive impairment
in marijuana use, [link]
in schizophrenia, [link], [link], [link]f, [link], [link]f, [link], [link]
Cognitive remediation therapy, for schizophrenia, [link]
Colleges
drinking issues, [link]
suicide prevention programs, [link], [link], [link]t, [link], [link]
Columbia TeenScreen Program (CTSP), [link], [link]t, [link]
Combined drug and psychosocial treatments
anxiety disorders, [link]
eating disorders, [link]
major depressive disorder, [link], [link]
Commitment, organizational, [link]
Community
attitudes toward mental illness, [link], [link]t
depression prevention interventions, [link]
mental health service reform initiatives, [link]
positive youth development programs, [link], [link]t, [link]t
therapeutic, for substance use disorders, [link]
Community assessment centers, for substance abuse treatment, [link]
Community factors, in anxiety disorders, [link]
Community-system approach, for substance abuse prevention, [link]
Comorbidity issues
in evidence-based mental health services, [link]
in substance use disorders, [link], [link], [link], [link]
Competencies, as outcome of positive youth development, [link], [link]
Compliance therapy, for schizophrenia, [link]
Comprehensive College Initiative (CCI), [link]t, [link]
Comprehensive Community Mental Health Services for Children and Families (CMHSC), [link]
Compulsive disorders, in drug addiction, [link], [link]f
Conditioning, classical
in anxiety disorders, [link]
in substance use disorders, [link]
Conduct disorder, comorbidity
alcohol use disorders, [link]
anxiety, [link]
bipolar disorder, [link]
suicidal behavior, [link]
Confidentiality
in drug screening programs, [link], [link]
in suicide screening programs, [link]
Consent for services, minor, [link]
Contact effects, in reducing stigma of mental illness, [link], [link]
Contagion
anxiety disorders and, [link]
suicidal behavior and, [link], [link]
Context factors, in implementation and dissemination of evidence-based mental health services, [link]
Contingency management incentive systems, for substance use disorders, [link]
Contingent negative variation (CNV), in schizophrenia, [link], [link]t, [link]
Control, perceived, in anxiety disorders, [link]
Coping and Support Training (CAST), [link]
The Coping Cat Workbook, [link]
Coping skills strategies, in anxiety disorders, [link]
Coping with Depression–Adolescent version, [link]
“coping with stress” adaptation of, [link]
Corticotropin-releasing factor, in stress response, [link]
Cortisol
in adolescence, [link]
and dopamine activity, [link]
in schizophrenia, [link]
Counseling
firearms, [link], [link]t
genetic, in schizophrenia, [link]
school-based, [link], [link]t, [link], [link], [link]t
Counselors Care (C-CARE), [link]
Crack cocaine, [link]. See also[link]
Credentialing process, substance abuse treatment, [link]
Criminal behavior, and anxiety disorders, [link]
Cross-National Collaborative Group study, [link], [link]t
Cultural factors. See also[link]
in access to mental health services, [link]
in alcohol use disorders, [link]
in depression, [link]
in eating disorders, [link]
in positive youth development, [link]
Culture, organizational, [link]
Cutting, school professional findings, [link], [link]t
Dade County, Florida, suicide prevention program, [link]
“Dealing with it” approach, [link]
Delivery systems. See[link]
Dependence disorders, chemical. See[link]
Deployment focused model for treatment development, [link]
Depression
antepartum, [link]
with atypical features, [link]
brain abnormalities associated with, [link], [link]
with catatonic features, [link]
chronic, [link], [link]
cognitive diathesis-stress model, [link]
comorbidity
anxiety disorders, [link], [link], [link], [link]
substance use disorder, [link], [link], [link]
double, [link]
genetics, [link], [link]t
geriatric, [link]
help-Seeking behavior for, perceived effectiveness, [link], [link]t
hypothalamic-pituitary-adrenal axis hyperactivity, [link]
interpersonal vulnerability, [link]
major
age of onset, [link]
cognitive vulnerability to, [link]
combination therapy, [link], [link]
community attitudes toward, [link], [link]t
comorbidity, [link]
alcohol use disorders, [link]
dysthymia, [link]
eating disorders, [link], [link], [link]
impact on treatment outcome, [link], [link], [link]
diagnosis, [link], [link]t
versus dysthymic disorder, [link], [link]t
epidemiology, [link], [link]
family environment and, [link], [link]
family history and, [link]
gender and, [link], [link]
interpersonal vulnerability, [link]
personality/temperament and, [link]
pharmacotherapy. See also[link]
in adolescents, [link], [link]t
in adults, [link]
augmentation therapy, [link], [link]
combination therapy, [link]
with psychotherapy, [link]
prepubertal, versus adolescent-onset, [link], [link]
prevention programs, [link]
future directions and recommendations, [link]
indicated, [link]
research agenda, [link]
selective, [link]
universal, [link]
psychosocial therapy
in adults, [link]
in children and adolescents, [link]
with pharmacotherapy, [link]
preventive, [link], [link]
pubertal status and, [link]
rates, [link], [link]f
recurrence, [link], [link]
relationship to schizophrenia, [link]
research agenda, [link]
risk factors, [link], [link], [link]
sequelae to, [link], [link]
stress and, [link], [link]
subtypes, [link]
treatment research agenda, [link]
maternal
and offspring depression, [link], [link], [link]
and response to cognitive-behavioral therapy, [link], [link]f, [link]
with melancholic features, [link]
parental, and offspring depression, [link], [link], [link], [link]
pharmacotherapy. See[link]
postpartum, [link], [link]
postpsychotic, [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
rates, [link], [link]f, [link]f
relapse prevention, [link]
schizophrenia and, [link], [link]
school professional findings, [link], [link]t
self-propagating nature, [link]
specific vulnerability hypothesis, [link]
stress and, [link]
subsyndromal
cognitive-behavioral therapy for, [link]
as risk factor for major depression, [link]
treatment-resistant, [link]
Detoxification, [link]
Development
brain, during adolescence, [link] [link], [link]f, [link]
youth
applications, [link]
ecological approach, [link]
positive. See[link]
problem-centered approach, [link]
Developmental assets, in positive youth development, [link]
Developmental group therapy, for suicidal youth, [link]t, [link]
Developmental milestones, in schizophrenia, premorbid abnormalities, [link], [link]f, [link]f, [link]
Dextroamphetamine dependence, [link]. See also[link]
Diagnostic and Statistical Manual for Primary Care (DSM-PC), eating disorders criteria, [link]
Diagnostic and Statistical Manual of Mental Disorders-IV (DSM-IV) criteria
alcohol abuse and dependence, [link]
anorexia nervosa, [link], [link]t, [link]
bulimia nervosa, [link], [link]t
eating disorders, [link], [link]t, [link]t
schizophrenia, [link]
substance use disorders, [link], [link], [link]f
Dialectical behavioral therapy
for suicidal adults, [link]
for suicidal youth, [link]t, [link]
Diathesis-stress model of depression, [link]
Dietary restraint, definition, [link]
Dieting. See also[link]
anorexia nervosa and, [link]
bulimia nervosa and, [link]
definition, [link]
eating disorders and, [link], [link]
professionally administered
effects on eating behavior, [link]
effects on psychological status, [link]
research with adults, [link]
youth-based program, [link], [link]
Disorder, harmful dysfunction account of, [link]
Disorganization, in schizophrenia, [link]
Disruptive behavior disorders, plus depression, [link], [link]
Disulfiram, for alcohol use disorders, [link]
Divaloproex
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
maintenance therapy, [link]
with lithium, for bipolar disorder, [link]
Dopamine
in alcohol use, [link]
cortisol and, [link]
in drug addiction, [link], [link], [link]
in schizophrenia, [link]
in smoking, [link]
Dorsal lateral prefrontal cortex, developmental changes, [link]
Dot Probe Attention Allocation Task, [link]
Double depression, [link]
Drug abuse. See[link]
Drug Abuse Resistance Education (DARE), [link]
Drug Abuse Warning Network (DAWN), [link]
Drug courts, juvenile, [link]
Drug dealing, school professional findings, [link], [link]t
Drug screening. See[link], [link]
DSM-IV diagnostic criteria. See[link]
Duloxetine, for major depressive disorder, [link]
Dysbindin, as schizophrenia susceptibility gene, [link]
Dysthymic disorder
plus major depressive disorder, [link]
versus major depressive disorder, [link], [link]t
secondary, [link]
Eating disorders, [link]. See also[link]; [link]
combination therapy, [link]
community attitudes toward, [link], [link]t
comorbidity, [link], [link]
diagnostic criteria, [link], [link]t, [link]t, [link]
diagnostic migration, [link], [link]
dieting and, [link], [link]
epidemiology, [link], [link]t, [link]t, [link]
ethnic differences, [link]
etiology, [link]
medical complications, [link], [link]t, [link]
not otherwise specified, [link], [link], [link]
obesity as risk factor for, [link], [link]
outcome, [link], [link]
pharmacotherapy, [link], [link], [link]
prevalence, [link], [link]t, [link]t
prevention programs, [link]
combined, [link]
in high-risk populations and settings, [link]
research agenda, [link]
targeted, [link]
universal, [link]
primary care physician findings, [link], [link]t, [link], [link]t, [link], [link]t
psychosocial therapy, [link], [link], [link]
relapse prevention, [link], [link]
research agenda, [link]
risk factors, [link], [link]t, [link]
school professional findings, [link], [link]t
symptoms, [link]
treatment, [link]
guidelines, [link]
issues specific to adolescents, [link]
research agenda, [link]
weight restoration, [link]
Ecological approach to youth development, [link]
“Ecstasy” (MDMA) use
anxiety and, [link]
clinical aspects, [link]
evolution, [link]
liquid, [link]
Education. See[link]; [link]
Effectiveness, organizational requirements for, [link]
Electroencephalography
in anxiety disorders, [link]
in schizophrenia, [link]
Electrolyte abnormalities, in eating disorders, [link]t
Electrophysiology, in schizophrenia, [link]
Emergency department
adolescent use of, [link]
substance use identification, [link]
suicide prevention interventions, [link], [link]t
Emotion(s)
brain circuitry for, developmental shifts, [link]
expressed, reduction, family therapy for, [link]
positive, [link]
Emotional competence, as outcome of positive youth development, [link]
Emotional processing
in anxiety disorders, [link]
in schizophrenia, [link]
Emotional Stroop task, [link]
Endocrine changes. See[link]
Engagement, pursuit of, in positive psychology, [link]
Environmental factors
during adolescence, [link]
in anorexia nervosa, [link]
in anxiety disorders, [link]
in smoking, [link]
in substance use disorders, [link]
Epidemiologic Catchment Area Study, [link], [link]t
Escitalopram, for major depressive disorder, [link]
Estrogen
in schizophrenia, [link]
supplementation, in anorexia nervosa, [link]
Ethical issues, in anxiety disorders, [link]
Ethnicity. See[link]
Ethnocultural factors, in depression, [link]
Event-related potentials (ERPs)
advantages, [link]
in anxiety disorders, [link]
in schizophrenia
in children and adolescents, [link], [link]t
contingent negative variation (CNV), [link], [link]t, [link]
current research, [link]
gamma-band activity, [link]
late positive component (P300), [link], [link]t, [link]
mismatch negativity and postonset progression of abnormalities, [link]
P1/N1 asymmetry, [link]t, [link]
processing negativity (Np), [link]t, [link]
sensory gating, [link], [link]
Evidence-based mental health services, [link]
definition, [link]
national registry, [link]
organizational context findings, [link]
reform initiatives, [link]
research gaps
categorization of practices, [link]
comorbidity issues, [link]
diagnostic classification, [link]
implementation and dissemination, [link]
lab-to-clinic translatability, [link]
treatment development, [link]
summary and recommendations, [link]
system barriers, [link]
access, [link]
cultural, [link]
financing policies, [link]
fragmentation, [link]
lack of family-driven practices, [link]
regulatory practices, [link]
Evidence-based policies, [link]
Evidence-based practices
categorization, [link]
popularity, [link]
substance abuse treatment, [link]
Evidence-Based Practices Project (EBPP) for Suicide Prevention, [link]
Executive inhibitory circuitry defects, in substance use disorders, [link]
Exercise, weight-bearing, in anorexia nervosa, [link]
Exosystem, [link]
Exposure and ritual prevention (EX/RP), for obsessive-compulsive disorder, [link]t, [link], [link]
Exposure therapy, for anxiety disorders, [link], [link], [link]
Expressed emotions, reduction, family therapy for, [link]
Extracurricular activities, for positive youth development, [link]
Extrapyramidal side effects, in schizophrenia, [link]
Familial aggregation, in schizophrenia, [link]
Family-based interventions
in eating disorders, [link]
in major depressive disorder, [link]
in substance abuse, [link]
for suicidal youth, [link]t, [link]
Family-driven practices, lack of attention to, [link]
Family environment
anorexia nervosa and, [link]
anxiety disorders and, [link]
major depressive disorder and, [link], [link]
suicidal behavior and, [link], [link]
Family history
bipolar disorder and, [link]
major depressive disorder and, [link]
Family therapy
for anorexia nervosa, [link], [link]
attachment-based, for major depressive disorder, [link]
for bipolar disorder, [link]
functional, state-level implementation, [link]
for schizophrenia
in adolescents, [link]
in adults, [link]
for substance use disorders, [link]
for suicide attempters, [link]
Fat, body, fear of, as criterion for anorexia nervosa, [link]
Fear
versus anxiety, [link]
of body fat or weight gain, as criterion for anorexia nervosa, [link]
brain circuitry for, developmental shifts, [link]
stranger, absence of, schizophrenia and, [link]
Fear structures, in anxiety disorders
cognitive-behavioral therapy and, [link]
emotional processing theory and, [link]
Feeding problems, early, bulimia nervosa and, [link]
Females. See[link]
Financing
for evidence-based mental health services, [link]
for substance abuse services, [link], [link], [link]
for suicide prevention evaluation studies, [link]
Finding Hope and Help program, suicide prevention, [link]
Firearms
availability, suicide and, [link], [link], [link]
restriction programs, [link], [link]t
First (initial) onset, definition, [link] [link]
Flashback, [link]
Flow state
in positive psychology, [link]
in positive youth development, [link]
Fluid abnormalities, in eating disorders, [link]t
Flunitrazepam abuse, [link]
Fluoxetine
for bulimia nervosa, [link]
for generalized anxiety disorder, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t, [link]
with substance use disorder, [link]
for obsessive-compulsive disorder, [link]
for panic disorder, [link]
for phobia, [link]
for post-traumatic stress disorder, [link]
for selective mutism, [link]t, [link]
for suicide attempters, [link]
Flupenthixol, for schizophrenia, [link]t
Fluphenazine, for schizophrenia, [link]t, [link]
Fluvoxamine
for major depressive disorder, [link]
for obsessive-compulsive disorder, [link]
for panic disorder, [link]
for separation anxiety disorder, [link]
for social anxiety disorder, [link]t, [link]
Focus on Families Program, [link]
Follow-back studies, in schizophrenia, [link], [link], [link]t
Forget Me, [link]
FRIENDS program, [link]
Frontal-temporal circuitry, in schizophrenia, [link]
Frontal white matter volume, developmental changes, [link]
Functional family therapy, state-level implementation, [link]
Future expectations, positive, as outcome of positive youth development, [link]
Gamma-band activity, in schizophrenia, [link]
Gammahydroxybutyrate (GHB), [link]
Gang affiliation, and anxiety disorders, [link]
Gastrointestinal abnormalities, in eating disorders, [link]t
Gatekeeper training, for suicide prevention, [link]t, [link]
Gateway theory of substance abuse, [link], [link]
Gender differences
anorexia nervosa, [link]
anxiety disorders, [link]
major depressive disorder, [link], [link]
substance abuse treatment, [link]
substance use, [link]
suicide, [link]
Gene expression, hormones and, [link]
Generalized anxiety disorder, [link]
comorbidity, [link], [link]t
description, [link]
genetics, [link], [link]t
signs and symptoms, [link]t
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Genes, susceptibility
in anorexia nervosa, [link]
in schizophrenia, [link]
and adolescence, [link]
identification, [link]
in substance use disorders, [link]
Genetic counseling, in schizophrenia, [link]
Genetics, [link]
anorexia nervosa, [link]
anxiety disorders, [link], [link]t, [link]
bipolar disorder, [link], [link]t
bulimia nervosa, [link]
depression, [link], [link]t
schizophrenia, [link], [link], [link]
substance use disorders, [link] [link], [link]
suicidal behavior, [link]
Genome scans
in schizophrenia, [link]
in substance use disorders, [link]
Georgia Home Boy, [link]
Geriatric depression, [link]
Glucocorticoids, in stress response, [link]
Glutamate, in drug addiction, [link]
Gonadal hormones, and adolescent behavior, [link] [link]
Gordon, Robert, [link] [link]
Gray matter volume
developmental changes, [link] [link], [link]f
in schizophrenia, [link], [link]
Great Ormond Street criteria for eating disorders, [link]
Great Smoky Mountain Study, comorbidity findings, [link]
Group therapy
for bipolar disorder, [link]
for suicidal youth, [link]t, [link]
Growth hormone, in major depressive disorder, [link]
Growth retardation, in anorexia nervosa, [link]
Guanfacine, for post-traumatic stress disorder, [link]
Guidance counselors, [link], [link]t, [link], [link], [link]t
Gymnastics, anorexia nervosa and, [link]
Hallucinogens, [link]
Haloperidol
with lithium, for bipolar disorder, [link]
for schizophrenia, [link]t, [link]t, [link]t
Happiness, “authentic,” in positive psychology, [link]
Harm avoidance, and vulnerability to depression, [link]
Harvard Twin study, [link]
Hawaii, reform initiatives on delivery of evidence-based practices, [link]
Headache, depression and, [link]
Health insurance
adolescent
call to action, [link]
lack of, [link], [link]
managed care
behavioral, [link]
“carve-outs” for mental health care, [link], [link]
public, policy shift to, [link]
Health weight regulation (HWR) model, for eating disorder prevention, [link]
Help-Seeking behavior
perceived effectiveness, [link], [link]t
role of stigma, [link], [link]t
Hematopoietic abnormalities, in eating disorders, [link]t
Heroin use
behavioral therapy, [link]
clinical aspects, [link], [link]t, [link]t
detoxification, [link]
genetics, [link]
medications for long-term treatment, [link]
withdrawal, [link], [link]t
Heschl gyrus, in schizophrenia, [link]
Heterocyclic antidepressants, for major depressive disorder, [link]
High-risk studies, in schizophrenia, [link], [link], [link], [link]t, [link]
Hippocampus
in anxiety disorders, [link]
developmental changes, [link]
Hispanic Americans
depression, [link]
female suicide attempters, emergency department interventions, [link], [link]t, [link]
substance use, [link]
suicide rate, [link]
Home and Away, [link]
Homosexuality, suicidal behavior and, [link]
Hopelessness, suicidal behavior and, [link]
Hormonal changes. See[link]
Hormone replacement therapy, in anorexia nervosa, [link]
Hospitalism, [link]
HPA (hypothalamic-pituitary-adrenal) axis. See[link]
HPG (hypothalamic-pituitary-gonadal) axis, [link]
Human potential, in positive psychology movement, [link]
Hyperactivity. See[link]
Hypokalemia, in bulimia nervosa, [link]
Hypomania, in bipolar disorder, [link]
Hyponatremia, in anorexia nervosa, [link]
Hypophosphatemia, in anorexia nervosa, [link], [link]
Hypothalamic-pituitary-adrenal (HPA) axis
activation in puberty, [link] [link]
in anxiety disorders, [link]
in mood disorders, [link]
in schizophrenia, [link]
in schizotypal personality disorder, [link]
Hypothalamic-pituitary-gonadal (HPG) axis, [link]
Iceland, depression prevention program, [link]
Identity, positive, [link]
I'm Still Here, [link]
Imaging studies. See[link]
Imipramine
for major depressive disorder, [link], [link]t
for panic disorder, [link]
for separation anxiety disorder, [link]
Immunology, in anxiety disorders, [link]
Impulse control disorder, in drug addiction, [link], [link]f
Impulsivity
bulimia nervosa and, [link]
suicidal behavior and, [link]
Indicated prevention programs, [link]
anxiety disorders, [link]
definition, [link] [link]
major depressive disorder, [link]
suicide, [link]
Infant, depression in, stress and, [link]
Infertility, in anorexia nervosa, [link]
Information processing, in schizophrenia, event-related indices, [link], [link]t
Inhalant abuse, [link]
Initial onset, definition, [link] [link]
Innovation, diffusion of, organizational context findings, [link]
Inpatient treatment
anorexia nervosa, [link]
bipolar disorder, [link]
substance use disorders, [link]
Institute of Medicine, report on prevention of mental disorders, [link] [link] [link], [link]
Insurance. See[link]
Intelligent quotient, in children of schizophrenic parents, [link], [link]f
International Classification of Diseases, Tenth Revision (ICD-10), [link]
Internet interventions/surveys
anxiety disorders, [link]
eating disorders, [link]
reducing stigma of mental illness, [link]
suicidal behavior, [link]t, [link], [link]
Interpersonal relationships
alcohol use disorders and, [link]
anorexia nervosa and, [link]
depression and, [link]
suicidal behavior and, [link]
Interpersonal skills, as outcome of positive youth development, [link]
Interpersonal student conflict, school professional findings, [link], [link]t
Interpersonal therapy
for bipolar disorder, with social rhythm therapy, [link]
for bulimia nervosa, [link], [link], [link]
for major depressive disorder
in adolescents, [link]
in adults, [link], [link]
for schizophrenia, [link]
Interpretative threat bias, in anxiety disorders, [link]
Interventions in adolescence. See also specific types, e.g., [link]
effectiveness, [link]
pharmacological. See[link]
positive. See[link]
preventive. See[link]
psychosocial. See[link]
settings, [link]
types, [link]
Interview
motivational, in substance use disorders, [link]
psychiatric, in schizophrenia, [link]
Ipecac abuse, in bulimia nervosa, [link]
Job satisfaction, [link]
Juvenile drug courts, [link]
Juvenile justice system, substance abuse services, [link], [link]
Kentucky
anti-marijuana campaign, [link]
reform initiatives on delivery of evidence-based practices, [link]
Ketamine, [link]
Lab-to-clinic translatability, of evidence-based mental health services, [link]
Labels, stigma and, [link]
Lamotrigine, for bipolar disorder, [link]
Language delay, in schizophrenia, premorbid abnormalities, [link], [link]f
Leadership, organizational, [link]
Learning theories, in anxiety disorders, [link]
Legal issues, in suicidal behavior, [link]
Life Goals Program, for bipolar disorder, [link]
Life satisfaction, in positive youth development, [link]
Life Skills Training Program, [link]
Life stress, early
hypothalamic-pituitary-adrenal axis hyperactivity, [link]
major depression and, [link], [link]
Linkage disequilibrium studies, in schizophrenia, [link]
Linkage studies
in schizophrenia, [link]
in substance use disorders, [link]
Lithium
for anorexia nervosa, [link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
with antipsychotics, [link]
with divaloproex, [link]
maintenance therapy, [link]
for major depressive disorder, [link]
for schizophrenia, [link]
for suicide attempters, [link]
Locker searches, [link]
Locus ceruleus, in anxiety disorders, [link], [link]
LSD (lysergic acid diethylamide), [link]
MacArthur Foundation Youth Mental Health Network, [link]
Macrosystem, [link]
Magnetic resonance imaging
brain volumetric, in schizophrenia, [link]
functional, in anxiety disorders, [link]
in mood disorders, [link]
morphometric, in anxiety disorders, [link]
Magnetic resonance spectroscopy, in anxiety disorders, [link]
Magnetoencephalography, in schizophrenia, [link]
Maintenance/interventions, definition, [link] [link]
Major depressive disorder. See[link]
Males. See[link]
Malnutrition
maternal, anorexia nervosa and, [link]
medical complications, [link], [link]t
Maltreatment, depression and, [link], [link]
Managed care
behavioral, [link]
“carve-outs” for mental health care, [link], [link]
Mania. See also[link]
age of onset, [link]
comorbidity
anxiety disorders, [link]
attention-deficit/hyperactivity disorder, [link]
conduct disorder, [link]
substance abuse, [link]
diagnostic criteria, [link]
mixed, [link]
Marijuana use
anxiety and, [link]
clinical aspects, [link]
in gateway theory, [link]
genetics, [link]
mass media prevention campaigns, [link], [link]
prevalence, [link]f
in schizophrenia, [link]
treatment, [link], [link], [link], [link]
withdrawal, [link]
Marital behavioral therapy, for major depressive disorder, [link]
Mass media
drug abuse prevention campaigns, [link]
misinformation about mental illness, [link]
for reducing stigma of mental illness, [link]
suicide coverage, [link]
Maternal depression
and offspring depression, [link], [link], [link]
and response to cognitive-behavioral therapy, [link], [link]f, [link]
Maternal-infant therapy, for depression, [link]
Maternal malnutrition, anorexia nervosa and, [link]
Maudsley method, in anorexia nervosa, [link]
MDMA. See[link]
Meaning, pursuit of, in positive psychology, [link]
Media. See[link]
Medicaid
behavioral managed care, [link]
expansion of mental health services, [link]
funding in schools, [link], [link]
Medical disorders, depression and, [link]
Melancholic features, depression with, [link]
Menarche, early, bulimia nervosa and, [link]
Mental health disorders, [link]. See also specific disorders, e.g.,[link]
call to action, [link]
drug treatment of depression, [link]
early detection and treatment as prevention strategy, [link]
future directions, [link]
insurance coverage, [link]
research needs, [link]
universal prevention, [link]
confidentiality issues, [link], [link], [link]
diagnostic classification, research gaps, [link]
failure to treat, consequences, [link]
insurance coverage, [link], [link], [link]
interventions
pharmacological. See[link]
positive. See[link]
preventive. See[link]
psychosocial. See[link]
school-based. See[link]
settings, [link]
types, [link]
misinformation about, [link]
in primary care setting. See[link]
stigma of, [link]
in community attitudes, [link], [link]t
consequences, [link]
factors contributing to, [link]
reducing, [link], [link]
role in help-Seeking behavior, [link], [link]t
suicidal behavior and, [link]
treatment, [link]
definition, [link] [link]
effectiveness, [link]
evidence-based. See[link]
impact of stigmatization, [link]
inadequacy of resources, [link], [link], [link], [link]
minor consent for, [link]
Mental Health Parity Act, [link]
Mental health professionals
physician collaboration with, [link]
referral to
primary care physician practices, [link], [link]t, [link], [link], [link]t, [link]
school practices, [link], [link], [link], [link]t
Mental health services
access to
cultural barriers, [link]
in schools, [link], [link], [link]t, [link]t
survey findings, [link], [link], [link]
system barriers, [link]
delivery systems. See[link]
evidence-based. See[link]
in primary care settings. See under[link]
school-based. See under[link]
settings, [link]
substance abuse–related, [link], [link]
Mescaline, [link]
Mesosystem, [link]
Methadone, for opioid addiction, [link], [link]
Methamphetamine dependence, [link]. See also[link]
Methodological Epidemiologic Catchment Area Study, [link], [link]t
Mexican Americans
access to mental health services, [link]
depression in, [link]
Michigan, reform initiatives on delivery of evidence-based practices, [link]
Microsystem, [link]
Minnesota Twelve-Step model, for substance use disorders, [link], [link]
Minor consent for services, [link]
Molecular genetic studies, in schizophrenia, [link]
Molindone, for schizophrenia, [link]t
Monitoring the Future (MTF) study, [link]
Monoamine oxidase inhibitors, for major depressive disorder, [link]
Mood disorders, [link]. See also[link]; [link]
age of onset, [link]
biology, [link]
comorbidity
alcohol use disorders, [link]
eating disorders, [link], [link]
epidemiology and definitions, [link]
relationship to schizophrenia, [link]
research agenda, [link]
in schizophrenia, [link]
seasonal, [link]
suicidal behavior and, [link]
trait vulnerability factor common to, [link]
treatment, [link]
Mood stabilizers, [link], [link]t. See also specific drugs, e.g.,[link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
combination therapy, [link]
for schizophrenia, [link]
Moral competence, as outcome of positive youth development, [link]
Motivational interview, in substance use disorders, [link]
Motor deficits, in schizophrenia, [link], [link], [link]f, [link]f, [link]t, [link], [link], [link]
Multidimensional Anxiety Scale for Children (MASC), [link]
Multidimensional family therapy, for substance use disorders, [link]
Multisystemic therapy, for substance use disorders, [link]
Mutism, selective, [link]
maintenance of gains, [link]
treatment, [link]t, [link], [link]t
Myelinization
in schizophrenia, [link], [link]
Naltrexone
for alcohol use disorders, [link]
for opioid addiction, [link]
Narcotic abuse. See[link]
National Alliance for Mental Illness, [link]
National Annenberg Risk Survey of Youth (NARSY), [link], [link]t
National Comorbidity Survey, [link]
bipolar disorder, [link]
depression, [link], [link]f
National Household Survey on Drug Use and Health (NHSDUH), [link]
National Institute of Mental Health Center for Prevention Research, [link]
National Registry of Effective Practices (NREP), [link]
National Youth Anti-Drug Media Campaign, [link]
Native Americans
substance use, [link]
suicide prevention programs, [link]
suicide rate, [link]
Nefazodone, for major depressive disorder
in adults, [link], [link]
in children and adolescents, [link], [link]t
Negative affectivity
bulimia nervosa and, [link]
and vulnerability to depression, [link]
Negative cognitions, and vulnerability to depression, [link]
Negative life events
anorexia nervosa and, [link]
social support and, [link]
suicidal behavior and, [link]
Negative self-talk, reduction, for anxiety disorders, [link]
Negative symptoms, in schizophrenia, [link]
Networks of care, interorganizational, for substance abuse treatment, [link]
Neuregulin 1, as schizophrenia susceptibility gene, [link]
Neuroanatomic studies, in schizophrenia, [link]
Neurobehavioral deficits, in schizophrenia, [link]
Neurobiology
anxiety disorders, [link], [link]
schizophrenia, [link], [link]
substance use disorders, [link]
Neurochemistry, anxiety disorders, [link]
Neuroendocrine changes
during adolescence, [link] [link]
child abuse and, [link]
in eating disorders, [link]t
in schizophrenia, [link]
Neurogenesis, postnatal, [link]
Neuroimaging
in anxiety disorders, [link]
in mood disorders, [link]
in schizophrenia, [link]
in substance use disorders, [link]
Neurologic signs, in schizophrenia, premorbid abnormalities, [link]t, [link], [link], [link]
Neuropsychological deficits, in children of schizophrenic parents, [link]
Neuroticism
as risk factor for psychopathology, [link]
and vulnerability to depression, [link]
Neurotransmitter systems. See also specific types, e.g.,[link]
in anxiety disorders, [link]
maturation, [link]
New York, reform initiatives on delivery of evidence-based practices, [link]
Nicotine receptors, smoking and, [link]
Nicotine-replacement therapy (NRT), [link]
Novelty, amygdala response to, [link]
Np (processing negativity), in schizophrenia, [link]t, [link]
Nurse, school, [link]t
Nurse practitioner, school-based, [link]t
Obesity
anorexia nervosa and, [link]
bulimia nervosa and, [link]
depression and, [link]
professionally administered weight loss programs for, [link]
as risk factor for eating disorders, [link], [link]
Obsessive-compulsive disorder
in children and adolescents, [link]
description, [link], [link]
plus eating disorders, [link], [link]
genetics, [link]t
PANDAS subgroup, [link], [link]
rating scale, [link]
signs and symptoms, [link]t
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
investigational, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Obstetrics-gynecology, and early detection and screening of anxiety disorders, [link]
OCD. See[link]
Ohio, reform initiatives on delivery of evidence-based practices, [link]
Olanzapine
for anorexia nervosa, [link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
for post-traumatic stress disorder, [link]
for schizophrenia, [link]t, [link]t, [link]t, [link]
Ondansetron, for bulimia nervosa, [link]
Onset
first (initial), definition, [link] [link]
risk of, versus risk of relapse, [link] [link]
Opioid abuse
behavioral therapy, [link]
clinical aspects, [link], [link]t, [link]t
detoxification, [link]
genetics, [link]
medications for long-term treatment, [link]
withdrawal, [link], [link]t
Opioid pain relievers, [link]t, [link]
Opioid system, alcohol abuse and, [link]
Oppositional disorder, plus anxiety, [link]
Organizational context, impact on service delivery, [link]
Organizations
climate, [link]
culture, [link]
effectiveness studies, [link]
leadership, [link]
readiness to change, [link]
structure, [link]
work attitudes, [link]
Osteopenia, in anorexia nervosa, [link], [link]
Outward Bound, [link], [link]t
Overanxious disorder. See[link]
Overweight children and adolescents, professionally administered weight loss programs for, [link]
P300 (late positive component), in schizophrenia, [link], [link]t, [link]
P1/N1 asymmetry, in schizophrenia, [link]t, [link]
Pacific Islanders, suicide rate, [link]
Pain relievers, opioid, [link]t, [link]
PANDAS, [link], [link], [link]
Panic attacks, neuroticism and, [link]
Panic control treatment, [link]t, [link], [link]
Panic disorder
in children and adolescents, [link]
comorbidity, [link], [link]t
bipolar disorder, [link]
bulimia nervosa, [link]
description, [link]
genetics, [link], [link]t
prevention, [link]
rating scales, [link]
signs and symptoms, [link]t
suicidal behavior and, [link]
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Parent(s)
depressed
and offspring depression, [link], [link], [link], [link]
and response to cognitive-behavioral therapy, [link], [link]f, [link]
firearms counseling programs, [link], [link]t
physician likelihood of discussing adolescent mental health problems with, [link], [link]t
substance use by, and offspring substance use, [link]
suicidal, and offspring suicide, [link]
Parent-child interaction
in anxiety disorders, [link]
in suicidal behavior, [link]
Parent-child interaction treatment (PCIT), state-level implementation, [link]
Parenting dimension
in alcohol use disorders, [link]
in anxiety disorders, [link]
in depression, [link]
Parity, mental health service, [link], [link]
Paroxetine
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t
for panic disorder, [link]
Partnership for a Drug-Free America, [link]
Patterson's developmental theory of substance abuse, [link]
PCP (phencyclidine), [link]
P50–early sensory gating endophenotype, in schizophrenia, [link], [link]
Peer relations, [link]
alcohol use disorders and, [link]
anxiety disorders and, [link]
in children of schizophrenic parents, [link], [link]
depression and, [link]
smoking and, [link]
Pemoline, for ADHD plus substance use disorder, [link]
Penn Resiliency Program, [link], [link]t
Perfectionism, bulimia nervosa and, [link]
Performance-limited social anxiety, [link]
Perinatal events, anorexia nervosa and, [link]
Personal Assessment and Crisis Evaluation (PACE) clinic, [link]
Personal Growth Class (PGC), [link]
Personality
anorexia nervosa and, [link]
bulimia nervosa and, [link]
in children of schizophrenic parents, [link]
genetic contributions, [link]
major depressive disorder and, [link]
smoking and, [link]
Personality disorder(s)
borderline, plus suicidal behavior, dialectical behavioral therapy for, [link]
cluster C, plus anorexia nervosa, [link]
schizotypal, [link], [link]
HPA axis in, [link]
movement abnormalities, [link]
Pessimistic attributional style
suicidal behavior and, [link]
and vulnerability to depression, [link]
Pharmacotherapy, [link]
for anorexia nervosa, [link], [link]
for anxiety disorders
with cognitive-behavioral therapy, [link]
rationale, [link]
recommendations, [link]t
research agenda, [link]
for bipolar disorder
in adolescents, [link], [link]t
in adults, [link]
combination therapy, [link]
maintenance therapy, [link]
for bulimia nervosa, [link], [link]
for eating disorders, [link], [link], [link]
for generalized anxiety disorder, [link]t, [link], [link]
for major depressive disorder. See also[link]
in adolescents, [link], [link]t
in adults, [link]
augmentation therapy, [link]
combination therapy, [link]
with psychotherapy, [link]
for panic disorder, [link]t, [link], [link]
for phobia, [link]t, [link], [link]
for post-traumatic stress disorder, [link]t, [link], [link]
for schizophrenia, [link]
acute treatment, [link], [link]t
adjunctive agents, [link]
antipsychotic, [link], [link]t, [link], [link], [link]t
continuation and maintenance treatment, [link], [link]t
preventive, [link]
for selective mutism, [link]t, [link]
for separation anxiety disorder, [link]t, [link]
for social anxiety disorder, [link], [link]t, [link], [link]
for substance use disorders, [link]
for suicide attempters, [link]
Phencyclidine (PCP), [link]
Phenomics, [link]
Phobia
in children and adolescents, [link]
comorbidity, [link], [link]t
description, [link]
genetics, [link], [link]t
neuroticism and, [link]
signs and symptoms, [link]t
social. See[link]
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Physical abuse, suicidal behavior and, [link]
Physical activity modifications, in youth, [link]
Physician
primary care. See[link]
school-based, [link]t
Pimozide, for schizophrenia, [link]t
Pindolol, augmentation effect, in panic disorder, [link]
Pleasure, pursuit of, in positive psychology, [link]
Political interventions, for prevention of major depressive disorder, [link]
Popular culture, influences, [link]
Population stratification artifact, [link]
Positive emotions, [link], [link]
Positive identity, [link]
Positive prevention, [link], [link]
Positive psychology
definition, [link]
as goal of prevention programs, [link], [link]
integration with positive youth development field, [link]
as outcome target for anxiety prevention studies, [link]
principles, [link], [link]
Positive rehabilitation, [link]
Positive youth development, [link] [link]
for at-risk and troubled youth, [link]
description, [link]
future directions, [link]
gaps, [link]
glossary of terms, [link]
goals, [link], [link]
history, [link]
indicators of, [link]
institutions that enable, [link]
integration with positive psychology movement, [link]
natural history studies, [link]
overview, [link]
versus problem-centered approaches, [link]
programs, [link]
methodological issues, [link]
model, [link], [link]t
outcome studies, [link], [link]t
resiliency in, [link], [link]
for substance abuse prevention, [link], [link]
summary of current knowledge, [link]
working assumptions, [link]
Post-traumatic stress disorder
alcohol use disorders and, [link]
in children and adolescents, [link]
description, [link]
neuroticism and, [link]
prevention, [link], [link]
rating scales, [link]
signs and symptoms, [link]t
social support and, [link]
substance abuse and, [link]
treatment, [link]t, [link]t
in adults, [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Postpartum depression, [link], [link]
Poverty
depression and, [link], [link]
school mental health services and, [link]
Prefrontal cortex, developmental changes, [link] [link]
Prefrontal-striatal circuitry, in schizophrenia, [link]
Pregnancy prevention programs, [link]t
Premature birth, anorexia nervosa and, [link]
President's New Freedom Commission on Mental Health (2003), [link], [link]
Prevalence
lifetime, [link]
point, [link]
Prevalence rate, [link]
Prevention
definitions, [link] [link]
early detection and treatment as strategy for, [link]
positive, [link], [link]
Prevention programs, [link]. See also specific disorders
anxiety disorders, [link]
eating disorders, [link]
goals, [link]
historical context, [link]
major depressive disorder, [link]
pregnancy, [link]t
schizophrenia, [link], [link]
stages, [link]
substance use disorders, [link], [link]t
suicide, [link]
types, [link]
Primary care setting
adolescent mental health problems in, [link] [link]
identification, [link], [link]t, [link], [link]t, [link]
physician knowledge, [link]
physician responsibilities, [link], [link]t
prevalence, [link], [link]t
priority during physical exams, [link], [link]t
referral practices, [link], [link]t, [link], [link], [link]t, [link]
screening, [link], [link], [link]t
stigma concerns, [link], [link]
treatment
collaborative relationships, [link]
perceived effectiveness, [link]
poor rate of, [link]
practices, [link], [link]t
resources, [link], [link]
adolescent substance use problems in, identification, [link], [link], [link]
physician survey
findings, [link], [link]t
methodology, [link]
sample characteristics, [link], [link]t
summary and conclusions, [link]
Primary prevention, [link]
Problem behavior theory of substance abuse, [link]
Problem-centered approach to youth development, [link]
Problem-solving therapy
for anxiety disorders, [link]
for major depressive disorder, [link]
for schizophrenia, [link]
for suicidal adults, [link]
for suicide attempters, [link]
Project STAR, [link]
Promoting Alternative Thinking Strategies program, [link]t
Promotion programs, [link]. See also[link]
Propanolol, for post-traumatic stress disorder, [link]
Prosocial involvement, as outcome of positive youth development, [link]
Prosocial norms, [link]
Prospective studies, in schizophrenia, [link], [link], [link], [link]t
Protective factors, definition, [link] [link]
Pruning process
in brain development, [link] [link], [link]f, [link]
in schizophrenia, [link], [link]
Psilocybin, [link]
Psychiatric interview, in schizophrenia, [link]
Psychiatric symptoms, in schizophrenia, premorbid abnormalities, [link], [link]t, [link]
Psychiatry, and early detection and screening of anxiety disorders, [link]
Psychobehavioral influences, in alcohol use disorders, [link]
Psychodynamic therapy, brief, for major depressive disorder, [link]
Psychoeducation. See also[link]
anxiety disorders, [link]
bipolar disorder, [link]
depression, [link]
eating disorders, [link]
for reducing stigma of mental illness, [link]
schizophrenia, [link], [link], [link]
substance abuse, [link]
suicide prevention, [link], [link]t, [link]t
Psychological characteristics, of positive youth development, [link]
Psychological climate, [link]
Psychological debriefing, [link]
Psychological factors, in smoking, [link]
Psychologist
referral to, primary care physician practices, [link]
school, [link], [link]t
Psychology, positive
integration with positive youth development field, [link]
principles, [link], [link]
Psychopharmacotherapy. See[link]
Psychosocial assessment, in schizophrenia, [link]
Psychosocial rehabilitation, [link]
Psychosocial therapy. See also specific types, e.g.,[link]
for anorexia nervosa, [link], [link]
for anxiety disorders
with pharmacotherapy, [link]
rationale, [link]
recommendations, [link]t
research agenda, [link]
for bipolar disorder, [link]
for bulimia nervosa, [link], [link]
for eating disorders, [link], [link], [link]
for generalized anxiety disorder, [link]t, [link], [link]
lab-to-clinic translatability, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link]
with pharmacotherapy, [link]
preventive, [link], [link]
for obsessive-compulsive disorder, [link]t, [link], [link]
for panic disorder, [link]t, [link], [link]
for phobia, [link]t, [link]
for post-traumatic stress disorder, [link]t, [link], [link]
for schizophrenia, [link], [link]
for selective mutism, [link]t, [link]
for separation anxiety disorder, [link]t, [link], [link]t
for social anxiety disorder, [link], [link]t, [link]
for substance use disorders, [link]
for suicide attempters, [link], [link], [link]t
Psychotherapy. See also[link]
for major depressive disorder
cognitive-behavioral analysis system of, [link]
with pharmacotherapy, [link]
for suicidal behavior, [link], [link], [link]t
Psychoticism, in schizophrenia, [link]
Psychotropic drugs, [link]. See also specific type, e.g.,[link]
for eating disorders, [link]
Pubertal delay, in anorexia nervosa, [link]
Pubertal status
anorexia nervosa and, [link]
major depressive disorder and, [link]
Public health insurance, policy shift to, [link], [link]
Purging, in anorexia nervosa, [link], [link]t
Quantum Opportunities Program, [link]t
Queensland Early Intervention and Prevention of Anxiety Project, [link]t
Quetiapine, adjunctive, for bipolar disorder, [link]
Race/ethnicity
and access to mental health services, [link]
anorexia nervosa and, [link]
eating disorders and, [link]
substance use and, [link]
suicide and, [link]
Rapid Response (RR) emergency department intervention for suicidal adolescents, [link]t, [link]
Rating scales, anxiety, [link]
Reaction Index, [link]
Readiness to change, organizational, [link]
Reconnecting Youth (RY) Prevention Research Program, [link], [link], [link]
Refeeding, in anorexia nervosa, [link]
Referral practices
primary care physicians, [link], [link]t, [link], [link], [link]t, [link]
schools, [link], [link], [link], [link]t
Regulatory practices, in evidence-based mental health services, [link]
Rehabilitation, positive, [link]
Reimbursement, for substance abuse screening, [link]
Relaxation exercises, for anxiety disorders, [link]
Religious participation, for positive youth development, [link], [link]t
Research agenda, [link]
anxiety disorders, [link]
bipolar disorder, [link]
eating disorders, [link]
evidence-based mental health services, [link]
major depressive disorder, [link]
mood disorders, [link]
schizophrenia, [link]
substance use disorders, [link]
suicide prevention, [link]
Resiliency
in children of depressed parents, [link]
as goal of prevention programs, [link]
as outcome of positive youth development, [link], [link]
Respiratory system, in panic disorder, [link], [link]
Restrained eating, definition, [link]
Restricting subtype, of anorexia nervosa, [link], [link]t
Retrospective studies, in schizophrenia, [link], [link], [link]t
Revised Children's Manifest Anxiety Scale (RCMAS), [link]
Reward center dysregulation, [link], [link]
allostasis and, [link]
animal models, [link], [link]f, [link]f
imaging studies, [link]
pharmacotherapy for, [link]
Risk factors, definition, [link] [link]
Risk of onset, versus risk of relapse, [link] [link]
Risperidone
augmentation effect, in obsessive-compulsive disorder, [link]
for bipolar disorder
in adults, [link]
with lithium, [link]
for schizophrenia, [link]t, [link]t, [link]t, [link], [link]
Ritual prevention, for obsessive-compulsive disorder, [link]t, [link], [link]
Rogers, Everett, [link]
Rohypnol abuse, [link]
Roofies, [link]
Route-of-administration principle, addictiveness and, [link]
Sample size, for prevention studies, [link]
Schizophrenia, [link]
adolescent-onset, developmental precursors, [link]
age-at-onset, [link], [link], [link]f
brain circuitry in, [link]
frontal-temporal, [link]
implications for adolescence, [link]
prefrontal-striatal, [link]
brain developmental abnormalities and, [link], [link]
children at risk for, longitudinal studies, [link], [link], [link], [link]t, [link]
cognitive deficits, [link]
pharmacotherapy, [link]
comorbid syndromes, adjunctive treatments, [link]
defining, [link]
depression in, [link], [link]
diagnostic criteria, [link]
duration of untreated psychosis, outcome and, [link], [link]
early interventions
effectiveness, [link]
preventive strategies, [link]
early-onset, [link], [link]
educational interventions, [link], [link], [link]
electrophysiology, [link]
emotion-processing deficits, [link]
endophenotypes
definitions based on, [link]
gene-finding utility, [link]
molecular genetic studies, [link]
research findings, [link], [link]t, [link], [link]
etiology, [link]
event-related potential studies, [link], [link]t. See also[link]
first-episode
acute treatment, [link], [link]t, [link]
maintenance treatment, [link], [link]t
pharmacological management, [link], [link]t
psychotic relapses after, [link]
treatment of residual symptoms and comorbid syndromes, [link]
treatment-refractory, [link]
genetic counseling, [link]
genetic studies, [link], [link]
of association, [link]
and disease mechanisms, [link]
endophenotypes for, [link], [link]
of familial aggregation, [link]
future directions, [link]
of linkage, [link]
of psychiatric disorders transmitted, [link]
susceptibility genes, [link]
twin, [link]
magnetoencephalography, [link]
motor deficits, [link], [link], [link]f, [link]f, [link]t, [link], [link], [link]
natural history, [link]f
negative symptoms, [link], [link]
neuroanatomic studies, [link]
neurobehavioral deficits, [link]
neurobiology, [link], [link]
neuroendocrinology, [link]
outcome studies, [link]
overview, [link]
pathophysiology, in adolescence, [link]
pharmacotherapy, [link]
acute treatment, [link], [link]t
adjunctive agents, [link]
antipsychotics, [link], [link]t, [link], [link], [link]t
continuation and maintenance treatment, [link], [link]t
preventive, [link]
phenomenology, [link]
and genetics, [link]
and neural basis, [link]
research questions, [link]
positive symptoms, pharmacotherapy, [link]
premorbid abnormalities, [link]
age specificity, [link], [link]t, [link]
behavioral problems, [link], [link], [link]t, [link], [link], [link]
birth cohort studies, [link], [link], [link]t
cognitive deficits, [link], [link]f, [link], [link]f, [link], [link]
consistency of findings, [link], [link]t
developmental milestones, [link], [link]f, [link]f, [link]
follow-back studies, [link], [link], [link]t
high-risk studies, [link], [link], [link], [link]t, [link]
implications for preventive intervention, [link]
key precursors, [link]
language delay, [link], [link]f
motor deficits, [link], [link]f, [link]f, [link]t, [link], [link], [link]
neurologic signs, [link]t, [link], [link], [link]
psychiatric symptoms (nonschizophrenic), [link], [link]t, [link]
research needs, [link]
research strategies to identify, [link], [link]t
and vulnerability hypothesis, [link]
prevention efforts, [link], [link]
effectiveness, [link]
strategies, [link], [link]
targets for, [link]
primary care physician findings, [link], [link]t
prodromal symptoms, [link], [link]t, [link]f, [link]
acute treatment, [link], [link]t, [link]
characteristics, [link], [link]
early treatment projects, [link]
maintenance treatment, [link]
psychosocial assessment, [link]
psychosocial treatment, [link], [link]
cognitive-behavioral therapy, [link], [link]
cognitive remediation therapy, [link]
compliance therapy, [link]
family-oriented, [link]
interpersonal therapy, [link]
preventive, [link]
social skills training, [link]
relapses, [link]
research agenda, [link]
residual symptoms, adjunctive treatments, [link]
risk factors
developmental perspective, [link], [link]t
and prevention strategies, [link]
simple, [link]
spectrum of, [link]
stigmatization, [link], [link]t, [link]
substance abuse and, [link], [link]
suicidal behavior in, [link]
symptoms
assessment, [link]
dimensional groupings, [link]
early, and illness course, [link], [link]t, [link]f
heterogeneity, [link]
treatment, [link]
very early-onset, [link], [link]
Schizotaxia, [link], [link]
Schizotypal personality disorder, [link], [link]
HPA axis in, [link]
movement abnormalities, [link]
School-based health centers (SBHCs), [link], [link]t, [link]
School factors
in anxiety disorders, [link]
in suicidal behavior, [link], [link]
School nurse, [link]t
School refusal. See also[link]
and detection of anxiety disorders, [link]
Schools. See also[link]
counseling programs, [link], [link]t, [link], [link], [link]t
drug testing programs, [link]
educational interventions
drug abuse, [link]
eating disorders, [link]
for reducing stigma of mental illness, [link]
schizophrenia, [link], [link]
suicide prevention, [link], [link]t, [link]
health resources, [link], [link]t
mental health professional survey
findings, [link], [link]t, [link]t, [link]t, [link]t
methodology, [link], [link]t, [link]t, [link]
sample composition, [link], [link]t, [link]t
summary and conclusions, [link]
mental health services, [link]
availability, [link], [link], [link]t, [link]t
barriers to receiving, [link]
effectiveness, predictors of, [link], [link]t
evaluation of, [link], [link]t
identification procedures, [link], [link]t
job responsibilities, [link], [link]t, [link]t
in low-income versus high-income schools, [link]
referral procedures, [link], [link], [link], [link]t
time with students, [link]
positive youth development programs, [link], [link]t, [link]t
postvention programs, [link]
problems reported by school professionals, [link], [link]t
screening programs, [link]
anxiety disorders, [link]
substance use, [link]
suicide prevention, [link], [link]t
treatment process, mental health problems, [link], [link]t, [link]
treatment programs, suicide attempters, [link]
Screen for Child Anxiety Related Emotional Disorders, [link]
Screening
anxiety disorders, [link]
in primary care settings, [link], [link], [link]t
in psychiatric care settings, [link]
substance use, [link]. See also[link]
substance use disorders, [link], [link]
suicidal behavior, [link], [link]t
Seasonal affective disorder, [link]
Secondary prevention, [link]
Sedative use, genetics, [link]
Selective mutism, [link]
maintenance of gains, [link]
treatment, [link]t, [link], [link]t
Selective prevention programs, [link]
anxiety disorders, [link]
definition, [link] [link]
major depressive disorder, [link]
suicide, [link]
Selective serotonin and noradrenaline reuptake inhibitors, for major depressive disorder, [link]
Selective serotonin reuptake inhibitors
for anxiety disorder, with substance use disorder, [link]
for bulimia nervosa, [link]
for generalized anxiety disorder, [link], [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link], [link]t
with substance use disorder, [link]
for obsessive-compulsive disorder, [link]
for panic disorder, [link], [link]
for phobia, [link]
for post-traumatic stress disorder, [link], [link]
for separation anxiety disorder, [link]
suicidal ideation and, [link] [link], [link], [link], [link]
for suicide attempters, [link]
Self-determination, [link]
Self-efficacy, [link]
Self-esteem/social competence (SESC) model, for prevention of eating disorders, [link]
Self-harm, school professional findings, [link], [link]t
Seligman, Martin, [link]
Seligman program, for prevention of depression, [link], [link]t
Sensitization
pharmacological, [link]
to stimulants, [link]
Sensory gating, in schizophrenia, [link], [link]
Separation, depression and, [link]
Separation anxiety disorder
comorbidity, [link], [link]t
description, [link]
genetics, [link]
signs and symptoms, [link]t
treatment, [link]t, [link], [link], [link]t
Septal-hippocampal system, in anxiety disorders, [link]
Serotonin
in alcohol use, [link]
in anorexia nervosa, [link], [link]
in anxiety disorders, [link]
in smoking, [link]
in suicidal behavior, [link], [link]
Serotonin and noradrenaline reuptake inhibitors, selective, for major depressive disorder, [link]
Serotonin reuptake inhibitors, selective. See[link]
Serotonin transporter polymorphism
anxiety disorders and, [link]
and depression after exposure to child abuse, [link] [link]
Sertraline
for generalized anxiety disorder, [link]
for major depressive disorder
in adults, [link]
in children and adolescents, [link], [link]t
for obsessive-compulsive disorder, [link]
for panic disorder, [link]
for post-traumatic stress disorder, [link]
Service delivery systems
mental health
barriers, [link], [link]
organizational context findings, [link]
recommendations, [link]
reform initiatives, [link]
settings, [link]
substance abuse, [link]
emerging trends, [link]
limited assessment practices, [link]
limited scope and appropriateness, [link]
step-down, [link]
system change considerations, [link]
Services for Teens at Risk (STAR) Center Outreach program, [link]
Sex differences. See[link]
Sex hormones, and adolescent behavior, [link] [link]
Sexual abuse
anorexia nervosa and, [link]
post-traumatic stress disorder and, [link]
suicidal behavior and, [link]
victim identification, primary care physician findings, [link], [link]t
Sexual assault, depression and, [link]
Sexual behaviors, high-risk, alcohol-related, [link]
Sexual orientation, suicidal behavior and, [link]
Short stature, in anorexia nervosa, [link]
Sibling influences, in alcohol use disorders, [link]
Sibutramine, for bulimia nervosa, [link]
Signal transduction, in drug addiction, [link]
Signs of Suicide (SOS) Program, [link], [link]t, [link]
Skeletal abnormalities, in eating disorders, [link]t
Skills, Opportunities, and Recognition program, [link]t
Skin abnormalities, in eating disorders, [link]t
Slim body ideal
anorexia nervosa and, [link]
bulimia nervosa and, [link]
Smoking
and anxiety disorders, [link]
cessation
behavioral therapy, [link]
pharmacotherapy, [link]
research, [link]
clinical aspects, [link]
determinants, [link]
genetics, [link], [link]
and communication of risks, [link]
and nicotine dependence, [link]
prevalence, [link]f
zero-tolerance policies, [link]
Social anxiety disorder
in children and adolescents, [link]
description, [link]
plus eating disorders, [link], [link]
rating scales, [link]
signs and symptoms, [link]t
treatment, [link], [link]t, [link]t
in adults, [link], [link]
in children and adolescents, [link]
maintenance of gains, [link]
management of partial response and nonresponse to, [link]
Social Anxiety Scale for Children–Revised, [link]
Social competence, as outcome of positive youth development, [link]
Social Phobia and Anxiety Inventory for Children, [link]
Social rhythm therapy, interpersonal therapy with, for bipolar disorder, [link]
Social skills
deficits
depression and, [link]
schizophrenia and, [link], [link]
as protective factor in suicide, [link]
training
for major depressive disorder, [link]
for schizophrenia, [link]
Social support
anorexia nervosa and, [link]
anxiety disorders and, [link]
Social worker, school, [link], [link]t
Societal emphasis on thinness, [link], [link]
Societal factors, in alcohol use disorders, [link]
Society for Adolescent Medicine, eating disorders treatment guidelines, [link]
Socioeconomic status
depression and, [link], [link]
school mental health services and, [link]
Socioenvironmental factors, in smoking, [link]
Sociotropy, depression and, [link]
Span of apprehension, schizophrenia and, [link], [link]f
Special-education system, substance abuse identification in, [link]
Speedballing, [link]
Spence Children's Anxiety Scale, [link]
Sports participation, anorexia nervosa and, [link]
SSRIs. See[link]
State, reform initiatives on delivery of evidence-based practices, [link]
State Children's Health Insurance Program (SCHIP), [link],